These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21683309)

  • 1. Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease.
    De Cassan C; De Vroey B; Dussault C; Hachulla E; Buche S; Colombel JF
    J Crohns Colitis; 2011 Aug; 5(4):364-8. PubMed ID: 21683309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E; Leccese P; Olivieri I; Latanza L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Behçet's disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis.
    Chung SH; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    World J Gastroenterol; 2013 Aug; 19(32):5389-92. PubMed ID: 23983446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS; Choi EK; Heo NY; Hong SC; Myung SJ; Yang SK; Kim JH; Song JK; Yoo B; Yu CS
    Dis Colon Rectum; 2007 May; 50(5):672-6. PubMed ID: 17216141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of Behçet's disease with various gastrointestinal findings.
    Tominaga K; Kamimura K; Takahashi K; Yokoyama J; Terai S
    Clin J Gastroenterol; 2018 Oct; 11(5):354-358. PubMed ID: 29667077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.
    Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of adalimumab in Behçet's disease. Description of 6 cases].
    Calvo Catalá J; Campos Fernández C; Rueda Cid A; González-Cruz Cervellera MI; Baixauli Rubio A; Pastor Cubillo MD
    Reumatol Clin; 2011; 7(4):258-61. PubMed ID: 21794828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab for sight-threatening uveitis in Behçet's disease.
    Mushtaq B; Saeed T; Situnayake RD; Murray PI
    Eye (Lond); 2007 Jun; 21(6):824-5. PubMed ID: 16601736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked improvement in gastric involvement in Behçet's disease with adalimumab treatment.
    Sonoda A; Ogawa R; Mizukami K; Fukuda K; Shuto M; Okamoto K; Matsunari O; Okimoto T; Murakami K
    Turk J Gastroenterol; 2017 Sep; 28(5):405-407. PubMed ID: 28797990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.
    Olivieri I; Leccese P; D'Angelo S; Padula A; Nigro A; Palazzi C; Coniglio G; Latanza L
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S54-7. PubMed ID: 21968237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy.
    Ariyachaipanich A; Berkelhammer C; Nicola H
    Inflamm Bowel Dis; 2009 Dec; 15(12):1769-71. PubMed ID: 19177427
    [No Abstract]   [Full Text] [Related]  

  • 12. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
    Hatemi I; Hatemi G; Pamuk ON; Erzin Y; Celik AF
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with adalimumab in a patient with coexisting Behçet's disease and ankylosing spondylitis.
    Yildiz N; Alkan H; Ardic F; Topuz O
    Rheumatol Int; 2010 Sep; 30(11):1511-4. PubMed ID: 19705123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report.
    Marsili M; Marzetti V; Lucantoni M; Lapergola G; Gattorno M; Chiarelli F; Breda L
    Ital J Pediatr; 2016 Sep; 42(1):81. PubMed ID: 27600159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal Behçet's disease: Manifestations, diagnosis, and management.
    Manuelyan Z; Butt E; Parupudi S
    Dis Mon; 2024 Jan; 70(1S):101674. PubMed ID: 38185603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
    Olivieri I; D' Angelo S; Padula A; Leccese P; Mennillo GA
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S112. PubMed ID: 19796550
    [No Abstract]   [Full Text] [Related]  

  • 17. A child with Behçet's disease presenting with a spectrum of inflammatory manifestations including epididymoorchitis.
    Pektaş A; Devrim I; Beşbaş N; Bilginer Y; Cengiz AB; Ozen S
    Turk J Pediatr; 2008; 50(1):78-80. PubMed ID: 18365598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entero-Behçet's disease coexisting with long-term epilepsy and schizophrenia-like symptoms.
    Ohtsuka T
    J Dermatol; 2014 May; 41(5):424-6. PubMed ID: 24750420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Behçet's disease with adalimumab].
    Callejas-Rubio JL; Sánchez-Cano D; Ríos-Férnandez R; Ortego-Centeno N
    Med Clin (Barc); 2008 Oct; 131(11):438-9. PubMed ID: 18928730
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurological complications of Behçet's syndrome.
    Kidd D
    Curr Neurol Neurosci Rep; 2012 Dec; 12(6):675-9. PubMed ID: 23007835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.